A combination of cytokines EGF and CNTF protects the functional beta cell mass in mice with short-term hyperglycaemia

Diabetologia. 2016 Sep;59(9):1948-58. doi: 10.1007/s00125-016-4023-3. Epub 2016 Jun 18.

Abstract

Aims/hypothesis: When the beta cell mass or function declines beyond a critical point, hyperglycaemia arises. Little is known about the potential pathways involved in beta cell rescue. As two cytokines, epidermal growth factor (EGF) and ciliary neurotrophic factor (CNTF), restored a functional beta cell mass in mice with long-term hyperglycaemia by reprogramming acinar cells that transiently expressed neurogenin 3 (NGN3), the current study assesses the effect of these cytokines on the functional beta cell mass after an acute chemical toxic insult.

Methods: Glycaemia and insulin levels, pro-endocrine gene expression and beta cell origin, as well as the role of signal transducer and activator of transcription 3 (STAT3) signalling, were assessed in EGF+CNTF-treated mice following acute hyperglycaemia.

Results: The mice were hyperglycaemic 1 day following i.v. injection of the beta cell toxin alloxan, when the two cytokines were applied. One week later, 68.6 ± 4.6% of the mice had responded to the cytokine treatment and increased their insulin(+) cell number to 30% that of normoglycaemic control mice, resulting in restoration of euglycaemia. Although insulin(-) NGN3(+) cells appeared following acute EGF+CNTF treatment, genetic lineage tracing showed that the majority of the insulin(+) cells originated from pre-existing beta cells. Beta cell rescue by EGF+CNTF depends on glycaemia rather than on STAT3-induced NGN3 expression in acinar cells.

Conclusions/interpretation: In adult mice, EGF+CNTF allows the rescue of beta cells in distress when treatment is given shortly after the diabetogenic insult. The rescued beta cells restore a functional beta cell mass able to control normal blood glucose levels. These findings may provide new insights into compensatory pathways activated early after beta cell loss.

Keywords: Acinar cell; Beta cell; Cell protection; Cytokine; Hyperglycaemia; Neurogenin 3; Transdifferentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alloxan / toxicity
  • Animals
  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Blood Glucose / drug effects
  • Ciliary Neurotrophic Factor / therapeutic use*
  • Epidermal Growth Factor / therapeutic use*
  • Hyperglycemia / drug therapy*
  • Insulin / metabolism
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Signal Transduction / drug effects

Substances

  • Basic Helix-Loop-Helix Transcription Factors
  • Blood Glucose
  • Ciliary Neurotrophic Factor
  • Insulin
  • Nerve Tissue Proteins
  • Neurog3 protein, mouse
  • Epidermal Growth Factor
  • Alloxan